<DOC>
	<DOC>NCT03101189</DOC>
	<brief_summary>So far, ACT-541468 has been studied mainly in Caucasian subjects. The present study will bridge results obtained in Caucasian subjects to those in Japanese subjects.</brief_summary>
	<brief_title>A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects</brief_title>
	<detailed_description />
	<criteria>Key Signed informed consent form; Healthy male and female subjects aged between 20 and 50 years (inclusive) at screening; Negative serum pregnancy tests at screening and negative urine pregnancy test at Day 1 for women of childbearing potential and agreement to use a reliable method of contraception for at least 90 days after last study drug intake; Body mass index (BMI) of 18.0 to 26.0 kg/m2 (inclusive) at screening; Healthy on the basis of physical examination, cardiovascular assessments and laboratory tests; Caucasian or Japanese ethnicity. Japanese subjects only: must be of native Japanese descent (all parents/grandparents of Japanese descent); must not have been away from Japan for more than 10 years (at screening visit); lifestyle should not have changed significantly since relocation from Japan. Key Any contraindication to the study treatments; History or clinical evidence of any disease or medical / surgical condition or treatment, which may put the subject at risk of participation in the study or may interfere with the absorption, distribution, metabolism or excretion of the study treatments; History of narcolepsy or cataplexy or modified Swiss narcolepsy scale total score &lt; 0; Any circumstances or conditions, which, in the opinion of the investigator, may affect full participation in the study or compliance with the protocol.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>safety</keyword>
	<keyword>Japanese</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>